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a b s t r a c t 
Metaplastic breast carcinoma is an uncommon malignant tumor with various pathologic 
subtypes. Diagnosis is often challenging due to the wide spectrum of clinical and imag- 
ing presentations. Here, we present the case of a very rare subtype of metaplastic breast 
carcinoma—a mixed-type metaplastic breast cancer with osseous differentiation in a 55- 
year-old female patient. The clinical presentation, imaging-pathology diagnosis, and treat- 
ment options are reviewed. Knowing this rarely reported but aggressive breast cancer is very 
important for clinicians to establish a timely diagnosis for effective management. 
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
Introduction 
Metaplastic breast carcinoma (MBC) is an uncommon invasive 
tumor that makes up less than 1% of primary breast cancers 
[1] that was not recognized as a distinct histologic entity 
until 2000 [2] . MBC is a heterogeneous disease with many 
pathologic subtypes characterized by a mixture of adenocar- 
cinoma with components of squamous, spindle, osseous, and 
chondroid differentiation [1] . It is challenging to diagnose 
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MBC because it has a broad spectrum of imaging and clinical 
presentations. Radiologists and clinicians have limited expe- 
rience in the diagnosis and management of MBC because it is 
an uncommon disease and is poorly documented in literature. 
Here, we report a case of a very rare subtype of MBC—a 
mixed-type metaplastic breast cancer with osseous differen- 
tiation. The multimodality imaging features along with the 
pathology correlation is presented and the multidisciplinary 
treatment approach is also reviewed. This case report will aug- 
ment our understanding of this rare subtype of MBC. 
https://doi.org/10.1016/j.radcr.2020.11.001 
1930-0433/© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. This is an open access article under the 
CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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Fig. 1 – Mammogram craniocaudal (A) and mediolateral 
oblique (B) views of the left breast demonstrate a 
circumscribed irregular mass with coarse calcifications in 
the posterior 12 o’clock axis. The triangular marker 
indicates the palpable concern. 
Case report 
A 55-year-old female presented with a palpable abnormality in 
the left breast. The patient had no personal or family history 
of breast cancer. Bilateral mammograms were performed and 
showed a 35-mm circumscribed irregular mass with coarse 
calcifications in the left breast at 12 o’clock located 8 cm from 
the nipple ( Fig. 1 ). This correlated with the palpable concern. 
A focused ultrasound was performed in the area of con- 
cern for further evaluations and indicated an irregular mass 
with internal vascularity measuring 39 × 21 × 29 mm ( Fig. 2 ). 
The mass was predominantly hypoechoic with an echogenic 
component corresponding to the coarse calcifications on 
the mammogram. The noncalcified component demonstrated 
posterior acoustic enhancement. The mass appeared to be in 
close proximity to the underlying pectoralis muscle. A focused 
ultrasound was also performed in the left axilla and showed 
a few normal lymph nodes (images not shown). 
A percutaneous core needle biopsy of the mass was per- 
formed with a 12-gauge spring-loaded needle device (Bard 
Marquee, Q123). Histopathology of the core biopsy indicated 
a mixed adenocarcinoma with a spindle area and osteoid ma- 
trix ( Fig. 3 ). Immunohistochemistry was negative for estrogen 
and progesterone receptors as well as HER2 and melanoma 
markers. Immunohistochemistry also indicated no specific 
mesenchymal, neural, muscle, or endothelial cell differenti- 
ation. 
A 1.5-Tesla magnet breast MRI was performed to delineate 
the extent of the cancer, especially the pectoral muscle 
involvement. The MRI indicated a mass with heterogeneous 
enhancement measuring 40 × 41 × 34 mm in the posterior 
left breast located at the 12:00 position ( Fig. 4 ). The kinetics 
showed at worst a rapid initial enhancement followed by 
washout. This enhancing mass contained an artifact from 
the biopsy clip consistent with the biopsy proven malignancy. 
The mass was compressing the pectoralis major without def- 
inite muscular enhancement. However, the fat plane between 
the mass and the pectoralis major was obliterated. CT images 
of the chest, abdomen and pelvis showed the biopsied left 
breast mass and calcifications of bone density without distant 
metastasis ( Fig. 5 ). 
The patient underwent a lumpectomy of the left breast, in- 
cluding a resection of the left breast cancer as well as a por- 
tion of the underlying pectoralis major given its proximity to 
the cancer. The patient also underwent 4 cycles of Carboplatin 
and Taxol chemotherapy treatment in addition to radiation 
therapy. 
The patient was recommended to have a routine an- 
nual clinical follow-up with bilateral mammograms. At the 
1-year follow-up, the patient denied any major complaints. 
No masses were felt on physical examination or seen on the 
mammograms. 
Discussion 
MBC is an uncommon, heterogeneous group of cancer 
with various pathologic subtypes. Mixed MBC with osseous 
Fig. 2 – Ultrasound imaging demonstrates a circumscribed irregular mass with rim vascularity at the area of palpable 
concern. The internal echotexture is heterogeneous. The echogenic area (arrow) corresponds to the coarse calcification on 
mammogram. The noncalcified component shows posterior acoustic enhancement (circle). 
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Fig. 3 – Histopathologic findings with (J) lower and (K) higher power magnification showing the interface between the 
spindle area and osteoid matrix. 
Fig. 4 – MRI images [(F) Maximum Intensity Projection Image, (G) T1 without contrast, (H) T1 with contrast enhancing, and (I) 
T1 with contrast and color mapping] show a circumscribed mass with a kinetics pattern of at worst rapid initial 
enhancement followed by washout at the left breast. There is a signal void from the biopsy clip in the center of this 
enhancing mass. This mass is close to the pectoralis muscle. 
differentiation is a very rare subtype with limited literature 
reports [3] . The median age at the time of presentation is 
48-59 years and it usually presents as a rapidly growing 
palpable mass generally greater than 2.0 cm in presentation 
[2] . Despite its large size, axillary involvement is much less 
common (6%-26% of cases) when compared with invasive 
ductal carcinoma [2] . MBC demonstrates a tendency to spread 
to lung and bone tissue by hematogenous means [4] . 
Histologically, MBC is a poorly differentiated heteroge- 
neous tumor containing ductal carcinoma cells mixed with 
areas of spindle, squamous, chondroid, or osseous elements 
[5] . The wide range of microscopic appearances of MBC has re- 
sulted in a variety of classifications and designations with the 
World Health Organization dividing MBC into epithelial and 
mixed types [6] . The mixed type category is further divided 
into carcinosarcomas, carcinomas with chondroid differenti- 
ation and carcinomas with osseous differentiation. The broad 
spectrum of MBC pathology often leads to various clinical and 
imaging presentations which makes its diagnosis and treat- 
ment challenging. 
MBC often demonstrates triple negative biomarkers (es- 
trogen receptor, progesterone receptor and Her2-neu) and as 
such is difficult to treat. When compared with other breast 
cancers, there are fewer therapeutic options and the out- 
comes are generally poorer with a higher recurrence rate. 
Previous studies indicate that MBC has a poor response to 
systemic chemotherapy and that neoadjuvant chemotherapy 
has little effect in preventing its progression [7] . Thus, ag- 
gressive surgical interventions with wide local excision of 
the lesion are often required due to the high recurrence rate. 
However, there is no consensus of the specific surgical mar- 
gins. 
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Fig. 5 – CT axial (D) and sagittal (E) images of the chest show the left breast mass with calcifications of dense bone density. 
The mixed MBC with osseous differentiation we reported 
is a very rare subtype of MBC. It has a few unique imaging fea- 
tures that make it more difficult to diagnose as it often demon- 
strates benign features that hide its malignant nature. MBC 
commonly presents as a round and circumscribed mass with 
posterior acoustic enhancement, rather than the irregular 
shape and posterior acoustic shadowing that is demonstrated 
in other malignant breast cancers [ 3 ,8 ]. The dense calcifica- 
tions that were observed in the case report are the “bone”—
osseous components of the lesion which are not commonly 
seen in the breast cancer [8] . The circumscribed mass and 
coarse calcifications can mimic benign fibroadenoma with 
hyalinized calcifications or trauma with dystrophic calcifica- 
tions. A history of rapid growth and high clinical suspicion 
will help differentiate MBC from other benign breast condi- 
tions. Multimodality imaging, including a breast MRI, defines 
the extent of the disease and CT imaging helps rule out metas- 
tasis. In this case, a multidisciplinary clinical team decided on 
a wide surgical excision with chemoradiation therapy and the 
patient responded well to this treatment approach. 
Conclusion 
Mixed MBC with osseous differentiation is a very rare type 
of breast cancer that often presents as a circumscribed mass 
with coarse calcifications on imaging. As a triple negative 
breast cancer, it is limited in the available treatment options. 
Timely diagnosis and wide surgical resection are keys for suc- 
cessful management of this rapidly growing cancer. 
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